Tag: glp_1_medications
-
Penn Study Links GLP-1 Medications to Lower Breast Cancer Risk
A Penn Medicine study suggests GLP-1 medications may reduce breast cancer risk in women aged 45-80. Researchers are intrigued by the drugs' unexpected impact on various pathways associated with cancer development.
HealthScience & TechnologyBusinessMediaMedical ScienceArtificial IntelligenceEducationLegalSocial IssuesEnvironment GLP-1 medicationsBreast CancerPenn MedicineCancer ResearchWomen's HealthMedical StudyElizabeth McDonald
-
Penn Celebrates Class of 2026, Research Milestones, and Campus Innovations
The University of Pennsylvania highlights the Class of 2026's diverse career paths, honors Knight-Hennessy Scholars, and showcases advancements in life sciences, academic research, and cultural initiatives, reflecting a vibrant campus.
HealthScience & TechnologyEducationSportMediaMedical ScienceSocial IssuesDigital and Print Publishing University of PennsylvaniaClass of 2026Knight-Hennessy ScholarsLife SciencesAcademic ResearchGLP-1 MedicationsPenn Museum